Compounds > bucladesine

bucladesine and Shock, Cardiogenic

bucladesine has been researched along with Shock, Cardiogenic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brenner, S; Döcke, WD; Oppert, M; Platzer, C; Prösch, S; Reinke, P; Riese, U; Volk, HD1
Imura, K; Ito, T; Ogawa, K; Satake, T1

Other Studies

2 other study(ies) available for bucladesine and Shock, Cardiogenic

ArticleYear
Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T-cells.
    Molecular and cellular biochemistry, 2000, Volume: 212, Issue:1-2

    Topics: Acute Disease; Aged; Bucladesine; Catecholamines; Cell Line; Cyclic AMP Response Element-Binding Protein; Epinephrine; Female; Humans; Interleukin-10; Jurkat Cells; Male; Middle Aged; Monocytes; Myocardial Infarction; Norepinephrine; Promoter Regions, Genetic; Shock, Cardiogenic; T-Lymphocytes; Transcriptional Activation; Transfection

2000
Hemodynamic effects of BTB-cyclic AMP in anesthetized dogs.
    Japanese heart journal, 1986, Volume: 27, Issue:5

    Topics: Animals; Blood Pressure; Bucladesine; Cyclic AMP; Dogs; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Myocardial Contraction; Shock, Cardiogenic; Stroke Volume; Vascular Resistance

1986